Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children
Status:
Completed
Trial end date:
2017-08-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the efficacy and safety of Eslicarbazepine acetate
(BIA 2-093) when given with other anti-epileptic drugs to treat children with partial
seizures whose condition has not been controlled by other drug treatments.